Emmaus Life Sciences, Inc. (EMMA) › Net IncomeEmmaus Life Sciences, Inc. (EMMA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2010: -$8.17M2011: -$8.87M2012: -$3.41M2013: -$10.91M2014: -$2.66M2015: -$3.38M2016: -$5.94M2017: -$7.11M2018: -$72.59M2019: -$54.84M2020: $1.35M2021: -$15.95M2022: -$10.62M2023: -$3.73M2024: -$6.45M2025: -$7.49M-$7.49M2010Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$7.49M-16.1%2024-$6.45M-72.9%2023-$3.73M+64.9%2022-$10.62M+33.4%2021-$15.95M-1277.7%2020$1.35M+102.5%2019-$54.84M+24.4%2018-$72.59M-920.5%2017-$7.11M-19.7%2016-$5.94M-75.8%2015-$3.38M-26.9%2014-$2.66M+75.6%2013-$10.91M-220.2%2012-$3.41M+61.6%2011-$8.87M-8.5%2010-$8.17M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share